Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |